Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

Deals > All

Total search results: 4379 | Ordered by Date (descending)
1 2 3 ... 42 43 44  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
4SC–Life Sciences Partners: investor conference, 201802 supply service 4SC AG presents at BioCapital Europe 2018 2018-02-06
Ablynx–Leucadia: investor conference, 201711 supply service Ablynx presents at Annual Jefferies Healthcare Conference London 2017-12-16
Evotec–Berenberg: investor conference, 201712 supply service Evotec presents at Berenberg European Conference in Surrey 2017-12-06
Abivax–Deutsche Börse: investor conference, 201711 supply service Abivax presents at Deutsches Eigenkapitalforum 2017 2017-11-28
Boehringer–BioMed X: pharma research, 201711– collab new BioMed X research group in bacterial modulation of innate immunity 2017-11-27
Evotec–Deutsche Börse: investor conference, 201711 supply service Evotec AG presents at Deutsches Eigenkapitalforum 2017 2017-11-27
Geneva Biotech–Sphere Fluidics: genomic technology, 201711– collab to develop large DNA cargo gene deliver + genome engineering systems 2017-11-27
Microbiotica–Instinctif Partners: public relations, 201711 service existent by Instinctif Partners 2017-11-27
Sphere Fluidics–Zyme Communications: public relations, 201711 service existent by Zyme 2017-11-27
LabGenius–SEVERAL: investment, 201711 seed financing round $3.66m co-led by Kindred Capital + Acequia Capital 2017-11-24
Nicox–Infopro Digital: investor conference, 201709 supply service Nicox presents at Actionaria 2017 in Paris 2017-11-23
Evotec–Volks- und Raiffensenbanken (DE): investor conference, 201711 supply service Evotec attends DZ Bank Equity Conference 2017 in Ffm 2017-11-22
Ablynx–Bryan Garnier: investor conference, 201711 supply service Ablynx participates at Bryan Garnier Annual Healthcare Conference in Paris 2017-11-17
Viewics–Roche: investment, 201711 acquisition of Viewics Inc by Roche 2017-11-17
Cosmo Pharmaceuticals–Leucadia: investor conference, 201711 supply service Cosmo attends Jefferies London Healthcare Conference 2017-11-16
Elpis BioMed–SEVERAL: investment, 201711 seed financing round led by Jonathan Milner + incl D Disley + W Janeway + N Starzacher 2017-11-16
Elpis BioMed–Zyme Communications: public relations, 201711 service existent by Zyme 2017-11-16
High-Tech Gründerfonds–EWE: investment, 201711 € 7-figure investment in HTGF III fund by EWE AG 2017-11-16
Laboratoires Réunis–bio.logis: genetic software, 201711 supply use of bio.logis GIMS by Laboratoires Réunis 2017-11-16
Philips–Nuance: healthcare informatics, 201711– collab product integration to bring AI into radiology reporting 2017-11-16
Spectro Analytical Labs (IN)–Eurofins: investment, 201711 acquisition of Spectro by Eurofins 2017-11-16
Twist Bioscience–Oxford Genetics: nucleic acid expression technology, 201711– license to SnapFast expression vectors to Twist Bioscience 2017-11-16
United States (govt)–Molecular Health: drug safety software, 201711–202210 extension collab with CDER for additional 5 years 2017-11-16
Calliditas Therapeutics–Optimum Strategic Communications: public relations, 201711 service existent by Optimum 2017-11-15
Erytech–Leucadia: investor conference, 201711 supply service Erytech at Jefferies London Healthcare Conference 2017 2017-11-15
Evotec–Leucadia: investor conference, 201711 supply service Evotec AG presents at Jefferies 2017 Global Healthcare Conference London 2017-11-15
Mind the Byte–Prosilico: drug discovery + development software, 201711– collab co-promotion + product integration 2017-11-15
Roche–Arvinas: protein degradation drugs, 201711– strategic license expansion for PROTAC technology to Genentech 2017-11-15
TxCell–Leucadia: investor conference, 201711 supply service TxCell attends Jefferies London Healthcare Conference 2017 2017-11-15
4SC–Stifel: investor conference, 201711 supply service 4SC presents at Stifel Nicolaus Healthcare Conference 2017 in NY 2017-11-14
Bayer–Loxo Oncology: TRK inhibitors, 201711– ww collab $400m upfront + $650m milestones developm of larotectinib + LOXO-195 2017-11-14
Biocartis–TopBio1: investment, 201711 DIVESTMENT off all shares (above 3% before) by TopBio1 LP 2017-11-14
Pharmaceuticals International–Quotient: investment, 201711 acquisition of Pharmaterials Ltd by Quotient Sciences Ltd 2017-11-14
Scipio Bioscience–BPCE: investment, 201711 seed financing round totalling €1.2m from Seventure Partners Quadrivium 1 Seed Fund + HTGF 2017-11-14
Scipio Bioscience–High-Tech Gründerfonds: investment, 201711 seed financing round totalling €1.2m from Quadrivium 1 Seed Fund + HTGF 2017-11-14
Scipio Bioscience–SEVERAL: investment, 201711 seed financing round €1.2m from Seventure Partners Quadrivium 1 Seed Fund + HTGF 2017-11-14
CRISPR Therapeutics–CureVac: mRNA technology, 201711– collab + license using RNArt techn to develop in-vivo gene-editing programs in liver diseases 2017-11-13
InflaRx–SEVERAL: investment, 201711 IPO $100m w 6.667m common shares at $15/share at Nasdaq Global Select Market 2017-11-10
Quotient–Zyme Communications: public relations, 201711 service existent by Zyme 2017-11-10
Horama–SEVERAL: investment, 201711 financing round Series B $22m 2017-11-09
Boehringer–MiNA Therapeutics: RNAa drugs, 201711– collab up to €307m plus royalties developm of RNAa drugs for fibrotic liver diseases incl NASH 2017-11-08
Lypro Biosciences–Cerenis: investment, 201711 acquisition €na of assets of Lypro Biosciences by Cerenis 2017-11-08
MiNA Therapeutics–MacDougall Biomedical Communications: public relations, 201711 service existent by MacDougall 2017-11-08
Beactica–Dong-A ST: investment, 201711 investment as new shareholder by Dong-A ST Co Ltd 2017-11-06
Beactica–SEVERAL: investment, 201711 financing round 2017-11-06
NousCom–5AM Ventures: investment, 201711 financing round Series B totalling €42m incl new + co-investor 5AM Ventures 2017-11-06
NousCom–Abingworth: investment, 201711 financing round Series B totalling €42m incl new + lead investor Abingworth 2017-11-06
NousCom–Huntsworth: public relations, 201711 service existent by Citigate Dewe Rogerson 2017-11-06
NousCom–Life Sciences Partners: investment, 201711 financing round Series B totalling €42m incl returning co-investor LSP 2017-11-06
NousCom–SEVERAL: investment, 201711 financing round Series B €42m led by new investor Abingworth + incl 5AM Ventures + LSP + Versant Ventures 2017-11-06
NousCom–Versant Ventures: investment, 201711 financing round Series B totalling €42m incl returning co-investor Versant Ventures 2017-11-06
Boehringer–Dicerna Pharmaceuticals: RNAi drugs, 201711– collab up to $201m plus royalties developm of RNAi drugs for chronic liver diseases incl NASH 2017-11-02
Evolva–SEVERAL: investment, 201710 capital increase CHF21.1m private placement to Pictet Asset Management + Cologny Advisors at CHF0.31/share 2017-11-02
Evolva–SEVERAL: investment, 201710 capital increase CHF65m discounted right offering 2017-11-02
Ocera Therapeutics–Mallinckrodt: investment, 201711– cash tender offer for Ocera Therapeutics Inc by sub of Mallinckrodt plc 2017-11-02
Topas Therapeutics–Boehringer: investment, 201711 extension of financing round Series A to €18m with €4m investment from BIVF 2017-11-02
AstraZeneca–Moderna Therapeutics: mRNA therapeutics, 201711– collab developm + commercialisation of AZD7970 for heart failure 2017-11-01
Apitope–Optimum Strategic Communications: public relations, 201710 service existent by Optimum 2017-10-31
Apitope–SEVERAL: investment, 201710– IPO at Euronext Brussels incl public offering in BE + private placement to qualified investors outside US 2017-10-31
BioGeneration Ventures–SEVERAL: investment, 201710 final closing of BGV III with €82m incl new investors BMS + JnJ + Schroder Adveq + MAN Pension 2017-10-31
Advanced Accelerator Applications–Novartis: investment, 201710– cash tender offer $3.9b with $41/ordinary share ANNOUNCED 2017-10-30
Aquila BioMedical~Concept Life Sciences: investment, 201710 acquisition of Aquila BioMedical Ltd by Concept Life Sciences 2017-10-30
Boehringer–Hospital Corp of America: clinical research, 201710– collab expansion clinical developm combi cancer treatments w Sarah Cannon 2017-10-30
Daiichi Sankyo–Glycotope: antibody-drug conjugates, 201710– option agreem €na for license + collab using Daiichi ADC technology with PankoMab-GEX 2017-10-30
IDBS–Danaher: investment, 201710 acquisition of IDBS by Danaher Life Sciences platform 2017-10-30
Theranexus–SEVERAL: investment, 201710 IPO €19.6m + €1.4m over-allotment option at Euronext Growth at €15.5/share 2017-10-30
Zebra Medical Vision–Blonde 2.0: public relations, 201710 service existent by Blonde 2.0 2017-10-27
Ablynx–Goodwin Procter: legal services, 201710 supply legal advice on $200m US IPO of Ablynx at Nasdaq by Goodwin 2017-10-26
AntibioTx–EU (govt): credit, 201710– EIB loan €20m to AntibioTx A/S for antibotics development 2017-10-26
Heidelberg ImmunoTherapeutics–Akampion: public relations, 201710 service existent by Akampion 2017-10-26
Phenex–Akampion: public relations, 201710 service existent by Akampion 2017-10-26
Provecs–Akampion: public relations, 201710 service existent by Akampion 2017-10-26
Tesaro–Evotec: drug discovery services, 201710– collab 3y €na r+d small-molecule candidates against I/O target 2017-10-26
JnJ–BioMed X: pharma research, 201710– collab up to five research projects in area of autoimmune disease w Janssen RnD LLC 2017-10-25
Concept Life Sciences–Zyme Communications: public relations, 201710 service existent by Zyme 2017-10-24
Fluidigm–Univ Zurich: mass cytometry s/w, 201710– ww distribution of histoCAT s/w with Hyperion Imaging System by Fluidigm 2017-10-24
ADC Therapeutics–SEVERAL: investment, 201710 private placement $200m 2017-10-23
DCPrime–Apceth: contract manufacturing, 201710– supply service manufacturing of DCP-001 DC vaccine by Apceth Biopharma GmbH 2017-10-19
High-Tech Gründerfonds–RWE: investment, 201710 investment 7-digit € of RWE Generation SE in HTGF III Fund 2017-10-19
Clinical Innovations–EQT: investment, 201710 acquisition by EQT Mid Market US Fund 2017-10-18
CureVac–Lilly: investment, 201710 equity investment $45m as part of mRNA cancer vaccines collaboration 2017-10-18
Lilly–CureVac: cancer vaccines, 201710– collab ww $50m upfront + $45m equity investment + $1.7b milestones up to 5 products using RNActive technology 2017-10-18
Novacyt–SEVERAL: investment, 201710 capital increase €9.7m with 14.74m new shares at €0.66/share 2017-10-18
SurgVision–Bracco: investment, 201710 acquisition of SurgVision BV by Bracco Imaging SpA 2017-10-18
GSK–Plasticell: stem cell technology, 201710– collab using CombiCult technology to produce hematopoietic cells 2017-10-17
Biogen–Genomics plc: drug target discovery, 201710– collab €na to discovery new drug targets for multiple sclerosis 2017-10-16
Institut Nehring–Eurofins: investment, 201710 acquisition of Institut Nehring GmbH by Eurofins 2017-10-16
Roche–Warp Drive Bio: drug discovery, 201710– strategic collab up to $387m plus royalties r+d of novel antibiotics using Genome Mining platform 2017-10-16
Apeiron–MC Services: public relations, 201710 service existent by MC Services AG 2017-10-13
Biom’Up–SEVERAL: investment, 201710 IPO €38.1m w 3.6m new shares at €10.5/share at Euronext Paris 2017-10-13
InflaRx–Bain Capital: investment, 201710 financing round Series D totalling $30m incl co-lead investor Bain Capital Life Sciences LP 2017-10-13
InflaRx–Cormorant: investment, 201710 financing round Series D totalling $30m incl co-lead investor Cormorant Asset Management LLC 2017-10-13
InflaRx–RA Capital Management: investment, 201710 financing round Series D totalling $30m incl co-lead investor RA Capital Management LLC 2017-10-13
InflaRx–SEVERAL: investment, 201710 financing round Series D $30m capital increase co-led by Bain Capital LS + Cormorant + RA Capital 2017-10-13
CRISPR Therapeutics–Chardan: investor conference, 201710 supply service CRISPR presents at Chardan Gene Therapy Conference in New York 2017-10-12
CRISPR Therapeutics–Leucadia: investor conference, 201710 supply service CRISPR presents at Jefferies Gene Technology Investor Summit in New York 2017-10-12
Kohlberg Kravis Roberts–Eurofins: investment, 201710– acquisition of LGC Forensics division of LGC Group from KKR 2017-10-12
Nestlé–Codexis: therapeutic enzymes, 201710– collab strategic alliance using CodeEvolver platform + incl option for ww developm of CDX-6114 2017-10-12
VirionHealth–Abingworth: investment, 201710 Series A financing up to £13m from Abingworth 2017-10-12
Ablynx–Consonance Capital: investment, 201710 ivnestment Consonance Capital CapMan GP LLC raised shareholding in Ablynx to 5.04% 2017-10-11
1 2 3 ... 42 43 44  next pagenext page



Advertisement

Picture [LSF] Life-Sciences-France.com – The Business Web Portal 600x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Biotech Showcase 2018 BTS San Francisco January 120x180px